相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。First-line disease modifying treatments in pediatric-onset multiple sclerosis in Greece: therapy initiation at more advanced age is the main cause of treatment failure, in a retrospective observational study, with a cohort from a single Multiple Sclerosis Center
Charalampos Skarlis et al.
NEUROLOGICAL SCIENCES (2023)
The epidemiology of acquired demyelinating syndrome in children: a complex opportunity to investigate the etiopathogenesis of multiple sclerosis
Maura Pugliatti et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2022)
HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?
Aigli Vakrakou et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease
Joanna Debska-Zielkowska et al.
CELLS (2021)
Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response
Dhon Romeo Makanga et al.
ONCOIMMUNOLOGY (2021)
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Ahmet Kursat Azkur et al.
ALLERGY (2020)
Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
Esther Melamed et al.
FRONTIERS IN IMMUNOLOGY (2020)
HLA-DPB1*03 as Risk Allele and HLA-DPB1*04 as Protective Allele for Both Early- and Adult-Onset Multiple Sclerosis in a Hellenic Cohort
Maria Anagnostouli et al.
BRAIN SCIENCES (2020)
Novel targeted therapies and immunotherapy for advanced thyroid cancers
George E. Naoum et al.
MOLECULAR CANCER (2018)
Update on multiple endocrine neoplasia Type 1 and 2
Abdallah Al-Salameh et al.
PRESSE MEDICALE (2018)
A comprehensive review of protein kinase inhibitors for cancer therapy
Radhamani Kannaiyan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical Experience
Gilles Salles et al.
ADVANCES IN THERAPY (2017)
Assessment of cancer risk with β-interferon treatment for multiple sclerosis
Elaine Kingwell et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
HLA-DRB1*15:01 and Epstein-Barr virus in a multiple sclerosis patient with psoriasis, nasopharyngeal and breast cancers. Lessons for possible hidden links for autoimmunity and cancer
Maria Anagnostouli et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
Cancer and multiple sclerosis in the era of disease-modifying treatments
Christine Lebrun et al.
JOURNAL OF NEUROLOGY (2011)
Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
Paul O'Connor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Risk of additional cancers in untreated and treated hairy cell leukemia patients
Constantin A. Dasanu et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway
Simona Dedoni et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Dimethylfumarate impairs melanoma growth and metastasis
Robert Loewe et al.
CANCER RESEARCH (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
